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Inflammatory reactions  to  various  kinds of stimuli  are  characterized  by  an 
increase in the number of macrophages derived from circulating monocytes at 
the site of inflammation and by a concomitant monocytosis (1-3).  The increase 
in  the  number  of macrophages  is  brought  about  by  an  increased  monocyte 
production in  the bone marrow,  which occurs by augmentation of the rate of 
division of the  monoblasts and promonocytes (4).  This process  is  regulated  in 
mice (3) and rabbits (5) by a  humoral factor called the factor increasing mono- 
cytopoiesis (FIM). 1 FIM is a  protein  that is synthesized and secreted by macro- 
phages at the site of inflammation and then transported  via the circulation to 
the bone  marrow,  where  it exerts its stimulatory action  (6,  7).  The  biological 
activity and physicochemical characteristics of FIM differ from those of colony- 
stimulating factor (CSF) (5,  6).  The increase of the number of macrophages in 
the inflammatory exudate in response to a  variety of stimuli has been shown to 
be controlled by a single, autosomal, dominant gene (8). The mechanism under- 
lying the genetic control of the magnitude of the inflammatory reaction remains 
to be elucidated. 
Since  monocyte production  during  an  acute  inflammation  is  stimulated  by 
FIM,  which  in  turn  gives  rise  to  increased  numbers  of macrophages  in  the 
inflammatory exudate,  it seemed possible  that high and  low responder  mouse 
strains differ with respect  to the production  of FIM or the  sensitivity of their 
monocyte precursor cells for this protein. This paper reports a study performed 
to discover whether the humoral regulation of monocyte production is genetically 
determined. 
Materials and Methods 
A~imals 
k  Specified pathogen-free, female CBA/Rij (H-2)  mice (REPGO-TNO,  Rijswijk, The 
b  Netherlands) and C57BL/10ScSnCpb (H-2) mice (The Central Institute for the Breeding 
of Laboratory Animals, TNO, Zeist, The Netherlands) were used at 6-12 wk of age. All 
This work was supported in part by the Nederlands Astma Fonds. 
J Abbreviation,s used il~  this paper:  AUC, area under curve; FCS, fetal calf serum; FIM, factor 
increasing monocytopoiesis;  LaS, serum from mice injected intraperitoneally with latex; SEL, saline 
extract of Listeria monoo.togelzes; SELS, serum of mice injected intraperitoneally with SEL. 
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mice were kept singly in cages and allowed to acclimate to the new environment (5).  In 
each experiment,  the  animals were matched  for age and  handled  in  a  random order. 
Sterilized food and tap water were given ad libitum. 
bTduction of a~ Acute h~flammation 
Latex.  An acute inflammation was induced by intraperitoneal injection of ~2.5 ×  108 
latex particles (Bactolatex, 0.81  ~m diam;  Difco Laboratories, Detroit,  MI) in  1 ml of 
sterile, pyrogen-free saline. This suspension contained <20 pg endotoxin, as assayed with 
the Limulus  amebocyte lysate  (LAL)  gelation  test  (9)  (kindly  performed by  Dr. J.  G. 
Kreeftenberg, Rijks Instituut voor de Volksgezondheid, Bilthoven, The Netherlands). 
Saline extract ofListeria monoc~,togenes.  A saline extract ofL. monocytogenes  (SEL) serotype 
1 (kindly provided by Dr. I.J.M.A.  Bakker-Woudenberg, Erasmus University, Rotter- 
dam,  The  Netherlands)  was  prepared  as described  by Galsworthy et  al.  (10)  with  an 
additional  extraction with 0.1  M  NaC1.  The saline-solute material was dialyzed against 
distilled water for 24 h, lyopbilized, dissolved in pyrogen-free saline at a concentration of 
10 mg/ml, passed through a 0.45 ttm Millex-HA filter unit (Millipore, Molsheim, France), 
and  stored  in  small  aliquots  at  -20°C  in  sterile  pyrogen-free tubes  (nontoxic  plastic; 
Falcon Labware, Oxnard, CA). This preparation contained <5 pg endotoxin per mg SEL 
(spectrophotometric lipopolysaccharide assay using chromogenic substrate  $2422  [11], 
kindly performed by Dr. L. L. M. Thomas, University Medical Centre, Amsterdam, The 
Netherlands).  An inflammatory reaction was evoked by injection of 1 mg SEL intraperi- 
toneally. 
Harvesting and Counting of Peritoneal Leukocytes 
Peritoneal cells were harvested under strict standard conditions, as described in detail 
elsewhere (2), with exactly 1.5 ml phosphate-buffered saline, pH 7.2 (Difco Laboratories), 
containing 50 U/ml heparin. The cells were counted in duplicate in a Biirker hemocytom- 
eter and characterized in Giemsa-stained cytocentrifuge preparations. The numbers of 
peritoneal cells were expressed per milliliter wash-out fluid since the total numbers could 
not be determined. 
Counting of Peripheral Blood Leukoc~,tes 
Peripheral blood was obtained by puncture of the orbital plexus with a 50 #1 capillary 
(Accupette; Dade Diagnostics, Miami, FL) and diluted with an equal volume of heparin. 
After further dilution in Isoton II (Coulter Electronics GmbH, Krefeld, Federal Republic 
of Germany) and  lysis of the erythrocytes by addition  of Lyse S (Coulter Electronics), 
leukocyte counts  were performed in  quadruplicate  with a  Coulter  Counter  model  ZF 
(Hoek-Loos, Schiedam, The Netherlands). The total numbers of monocytes, granulocytes, 
and lymphocytes were calculated  from the total number of leukocytes and differential 
counts of at least 400 leukocytes in four Giemsa-stained'blood smears, and were expressed 
per milliliter of blood. 
Prepa ration of Serum 
The preparation of serum has been described in detail elsewhere (3). 
Assay of FIM Activity 
In vitro assay.  For the assessment of FIM activity, cells  of the macrophage cell line 
PU5-1.8 (kindly donated by Dr. P. Ralph, Sloan-Kettering Institute for Cancer Research, 
Rye, NY), recovered from a log-phase culture in RPMI 1640 medium (Gibco Laboratories, 
Grand Island, NY) containing 10% fetal calf serum (FCS),  2 mM l.-glutamine,  1,000  U/ 
ml penicillin, and 50 ug/ml streptomycin were incubated in triplicate at a concentration 
of 2 x  105/ml culture medium that, instead of 10%  FCS, contained 8% FCS and 2% of 
the mouse serum under study. After overnight culture in Teflon culture bags (12) in a 
humidified  atmosphere of 7.5%  COs  in  air at  37°C,  the  cells were  counted  and  cell 
viability was assessed by trypan blue exclusion. The mean number of viable cells grown 
in culture medium containing 10% FCS was used as reference value (N~). The FIM activity 526  GENETIC CONTROL OF  MONOCYTE  PRODUCTION 
index (I) was calculated as the percentage increase of the number of cells in cultures with 
serum under investigation (Ns) in relation to the reference value (N~), according to the 
formula: I =  (NIN~ -  1) x  100. 
In vivo assay.  The ability of serum to induce monocytosis was assayed in normal test 
mice by determination of the number of blood monocytes in each animal at 24 h before 
and 24, 48, and 72 h after the intravenous injection of 0.2 ml of a serial twofold dilution 
in pyrogen-free saline. Since the number of blood monocytes in normal mice, whose blood 
is sampled only once a day for a leukocyte count, remains constant over a period of several 
days (manuscript in preparation), the time point 24 h before the serum injection was taken 
as time zero. Under these conditions, the animals were stressed only once a day. 
The monocytosis-inducing activity was expressed as the difference (A~4) between the 
number of blood monocytes in mice at time zero and at 24 h after injection of a serum 
sample (monocytes x  10 -6 x  m1-1) and also as the area under the curve (AUC) of the 
number of blood monocytes during 72 h after injection of the sample (monocytes ×  10 -6 
x  h x  ml  -~) calculated according to the formula, AUC -- 0.f' Ndt -  Not, in which N is the 
number of blood monocytes x  10-6/ml and t is the duration of the observtion period (i.e., 
72 h). 
Statistical Analysis 
In all in vivo experiments, at least four but usually five mice were used per time point. 
The in vitro experiments were performed in triplicate and the results expressed as the 
mean and standard  error of the mean.  To assess  the significance of differences within 
experiments,  we  used  Student's two-tailed test or the analysis of variance (13).  Unless 
stated otherwise, all P values mentioned refer to differences between treated and control 
mice or cultures. The extent to which the leukocyte response was influenced by a number 
of variables (considered in totality, 41) was assessed by covariance analysis with an IBM 
370/158  computer using the stepwise procedure in a  multiple regression analysis (14). 
The actual decisions as to whether a  particular variable must be added  to or removed 
from the multiple regression equation were based on P-to-enter and P-to-remove values, 
which were set at _-<0.05 and ->0.10, respectively. For the regression analyses, the following 
values were assigned arbitrarily in advance to the variable inflammatory agent: 0 (zero) 
for SEL and  1 for latex; for donor mouse strains, 0 (zero) for CBA and  1 for B10 mice; 
and for the recipient strains, 0 (zero) for CBA and 1 for B10 recipients. 
Results 
Number of Blood and Peritoneal Leukocytes in Normal BIO and CBA Mice 
The numbers of leukocytes in the peripheral blood and peritoneal cavity were 
determined  in B10 and CBA mice to obtain the normal values for these mouse 
strains.  The  results  show  a  slight  but  statistically  significant  difference  in  the 
number of blood monocytes between the two strains; small differences were also 
found  between  the  numbers  of granulocytes  and  lymphocytes of both  strains 
(Table  I).  The  number of macrophages in  the  peritoneal  cavity did  not  differ 
significantly between the two strains, but CBA mice had twice as many peritoneal 
lymphocytes as B 10 mice and half the number of peritoneal granulocytes (Table 
I). 
Course of Mononuclear Phagocyte Numbers in Response to Intraperitoneally 
Injected Sterile Inflammatory Agents 
To compare the magnitude of the cellular reaction in B10 and CBA mice, an 
inflammation  was  induced  in  the  peritoneal  cavity  by  injection  of  a  sterile 
particulate or soluble inflammatory stimulus. 
Peritoneal macrophages.  After an intraperitoneal injection of polystyrene latex SLUITER  ET  AL. 
TABLE  I 
Pool Sizes of Leukocytes of BlO and CBA Mice 
Number of leukocytes 
(x 106/ml) in mice of strain: 
B10  CBA 
Difference 
between B10 
and CBA 
Peripheral blood* 
Monocytes  0.25 (-+0.07)  0.19 (+_0.05) 
Granulocytes*  0.57 (-+0.23)  0.70 (+0.24) 
Lymphocytes  7.55 (-+1.57)  8.05 (-+1.48) 
Peritoneal cavity  i 
Macrophages  2.09 (_+0.48)  2.18 (+0.47) 
Granulocytes  0.03 (_+0.02)  0.01 (-+0.03) 
Lymphocytes  0.07 (+0.05)  0.15 (-+0.07) 
<0.0005 
<0.0005 
0.025 
NS 
0.005 
<0.0005 
* Values are means of 95 mice and the standard deviation. 
* Marginating pool is not taken into account. 
0 Values are means of 30 mice and the standard deviation. 
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FIGURE  1.  Course of the number ofmacrophages in the peritoneal cavity of C57BL/10 mice 
(0) and CBA mice (O) after an intraperitoneal injection of 1 ml of a latex suspension  (a) or 1 
mg SEL (b). 
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particles  into  B10  mice,  the  number  of peritoneal  macrophages  first decreased 
to a  minimum  at  6  h  (0.01  <  P  <  0.02)  and  then  increased  to  a  maximum  of 
5.10 (_+0.07) ×  106/ml at 48 h  (P<  0.001),  followed by a return to normal values 
at  72  h  (Fig.  1 a).  In  the peritoneal  cavity of CBA  mice,  the  number  of macro- 
phages decreased  after injection  of latex  to a  minimum  at  12  h  (P <  0.001)  and 
then  increased  slightly to a  maximum  of 3.02  (_+0.32)  x  106/mi at 48  h  (0.01  < 
P  <  0.02) (Fig.  1 a). 
After injection  of SEL into B10  mice, the number  of peritoneal  macrophages 
fell offto a  minimum  of 0.52 (_+0.08) x  106/ml at 6  h  (P<  0.001),  then increased 0.8" 
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rapidly to a  maximum of 3.96 (_+0.97) x  106/ml at  12 h (0.02 <  P  <  0.05), and 
remained at roughly that  level over the next 60 h  (Fig.  1 b). In  CBA mice, the 
number  of peritoneal  macrophages  also showed a  decrease  after  injection  of 
SEL, and  did not  return  to normal  values until  24  h  after injection,  but  then 
increased slightly to a  maximum  of 2.33  (_+0.20)  ×  106/ml at  72 h  (0.1  <  P  < 
0.2) (Fig.  1 b). 
These results show that,  for all inflammatory  stimuli used, the accumulation 
of peritoneal macrophages was greater in B 10 than in CBA mice. The difference 
between the AUC amounted for both stimuli to a factor of ~1.6. 
Blood Monoc~tes 
After the intraperitoneal  injection of latex,  the  number of blood monocytes 
of B10 mice reached a maximum of 7.09 (_+1.02) ×  105/ml at 24 h (0.01  <  P  < 
0.02) and  then  subsided to normal  values at  72 h  (Fig.  2a).  In  the peripheral 
blood of CBA mice, the number of monocytes increased rapidly to a maximum 
of 3.35  (+0.55)  ×  105/ml at 6  h  after  latex  injection  (0.02 <  P  <  0.05),  then 
decreased over the next  12 h, followed by a slight increase (Fig. 2 a) 
After the injection of SEL, the number of blood monocytes in B 10 mice rose 
to a  maximum  of 3.75  (+0.42)  ×  105/ml at  18  h  (0.01  <  P  <  0.02) and then 
returned  to the  normal  level over the next  30  h  (Fig.  2b).  The  course of the 
number  of monocytes in  the  peripheral  blood  of CBA  mice  remained  fairly 
constant after the injection of SEL, except for a statistically significant decrease 
at 6  h  (0.01  <  P  <  0.02) (Fig.  2b).  For latex and SEL, the difference between 
the AUC amounted to factors of 2.2 and  1.7, respectively, in favor of the B10 
mice. 
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FIGURE 2.  Course of the number of monocytes in the peripheral blood of C57BL/IO mice 
(0) and CBA mice ((3) after intraperitoneal injection of 1 ml of a  latex suspension (a) or 1 mg 
SEL (b). SLUITER  ET  AL.  529 
Demonstration of FIM Activity in Serum 
To find  out whether  the  difference in  inflammatory  response between B10 
and CBA mice expressed in the number of macrophages and blood monocytes 
was based on a difference in FIM production, the serum level of this protein was 
determined by in  vitro assay at various intervals after intraperitoneal  injection 
of the inflammatory stimulus. 
FIM activity was demonstrable in the serum of both B 10 and CBA mice given 
latex intraperitoneally; although differences were found between the two strains 
with  respect  to  the  course  of  FIM  activity  after  the  injection  of latex,  the 
maximum levels were almost the same (Fig. 3 a). 
After the intraperitoneal  injection of SEL, the serum of the two mouse strains 
showed almost synchronous courses of FIM activity and similar peak values (Fig. 
3 b). To rule out the possibility that these assay results were influenced by trace 
amounts of SEL in the serum,  20 ~g SEL was added to the cultures of the cell 
line,  under  the  assumption  that  all  intraperitoneally  injected  SEL  had  been 
diffused to the  blood compartment.  The  index  was -10.4  (Fig.  3b),  which  is 
significantly lower (0.02 <  P <  0.05) than the values obtained when normal BI0 
or CBA serum was added (FIM indices, 4.8 and -3.2, respectively.) 
Relationship  Between the Dose of h~ammatory Stimulus and FIM Activity 
in Serum 
To  determine  whether  the  index  of FIM  activity  is  related  to  the  dose of 
inflammatory  stimulus,  serial  twofold dilutions  of latex  in  saline  were injected 
intraperitoneally,  and  blood samples were taken  at time  points when  maximal 
activity would be expected (i.e., for B10 mice at 24 h and for CBA mice at 12 h) 
for in  vitro assays of FIM  activity in  serum.  The  results  showed that  in  both 
strains of mice the index of FIM activity increased with decreasing dilutions of 
latex until a maximum was reached at the dose normally given intraperitoneally 
(i.e.,  the  stock  suspension  containing  2.5  x  108  particles/ml);  however,  when 
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FIGURE 3.  Course of the index of ElM activity in serum of C57BL/10 mice (0) and CBA 
mice (O) at various time points after intraperitoneal injection of 1 ml of a latex suspension (a) 
or 1 rng SEL (b), determined by an in vitro bioassay (see Materials and Methods). The effect 
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double  this  concentration  of latex  particles  were administered,  the  index  was 
considerably lower than was found with stock suspension (Fig. 4). 
For a  simple  mathematical  analysis  of the  relation  between  FIM  activity in 
serum and the dose of latex given intraperitoneally, the log2 dose interval from 
-2  to  0  (zero)  was  considered  (Fig.  4).  The  regression  of the  index  of FIM 
activity (I) on the log2 dose of latex (dose) can be described for B10 mice by the 
equation: 
I  =  17.5 +  7.1  dose (r =  0.79), 
and for CBA mice by: 
I  =  19.5 +  11.7 dose (r =  0.95). 
Analysis of the covariance of these regression lines for homogeneity showed no 
significant differences in  their residual variances (0.10 <  P  <  0.25) and slopes 
(0.05 <  P  <  0.10), but their average slope (b) was found to be highly significant 
(b =  9.4; 0.001  <  P  <  0.005). This means that statistically these regression lines 
run parallel. The computed intercepts of the two regression lines with the y axis 
did not differ significantly (0.10 <  P  <  0.25), which means that the relationship 
between the index of FIM activity and the amount of latex injected intraperito- 
neally was identical for the two mouse strains. 
In Vivo Response to Serum Containing FIM 
The effect of serum with FIM activity on the number of circulating leukocytes 
was  studied  next.  For  this  purpose,  B10  and  CBA  mouse  sera  with  maximal 
activity, as  determined  in  the  in  vitro bioassay (Fig.  3a  and  b),  were  injected 
intravenously into normal B 10 and CBA recipient mice in serial twofold dilutions 
in  saline.  The  effect was  expressed as  the  difference between  the  number  of 
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FIGURE 4.  Index of FIM activity in serum of C57BL/10 mice (0) at 24 h and of CBA mice 
(O) at  12 h after injection of 1 ml of serial twofold dilutions of latex in saline. The stock 
suspension, whose Ioga value was put at zero, contained 2.5 x  10  a particles. SLUITER  ET  AL.  531 
leukocytes at time zero and at 24 h after injection (A~4) or as the AUC from time 
zero to 72 h. 
In B10 recipient mice, the Ae4 and AUC of the number of blood monocytes 
increased with  increasing doses of serum  from  B10  mice intraperitoneally in- 
jected with 1 mi latex (LaS24) and  1 ml SEL (SELS24)  24 h earlier (Figs. 5a, 6a). 
After the intravenous injection of LaSt2 and SELS~ from CBA mice, the number 
of monocytes in the peripheral blood of B10 mice also increased with the dose 
of serum (Figs. 5 a, 6 a). Neither LaS24 and SEES24 from B 10 mice nor LaSl~ and 
SELSl2 from CBA mice had any monocytosis-inducing effect on CBA recipient 
mice over the dose  range studied (Figs.  5b,  6b).  Apparently, CBA mice differ 
from B 10 mice in their ability to mount an increase of the number of monocytes 
in response to an injection of serum with FIM activity. The courses of the number 
of granulocytes and lymphocytes in the two strains did not change significantly 
in relation to the dose of any of the four sera under study (data not shown; for 
the statistical analysis of the data, see below). 
Statistical Analysis of Leukoc'~,te Response to Sera Containing FIM 
For an adequate analysis of the differences in leukocyte response between B10 
and  CBA  mice  in  relation  to  the dose of serum  under study, and to find out 
whether other variables also contribute to the differences in response, a multiple 
regression analysis on all of the data shown in Figs. 5 and 6 was performed. The 
regression equations found for the monocyte responses expressed as A24 (Table 
II, equation 1) or AUC (Table II, equation 2) confirmed that the dose-dependent 
effect of serum is determined by the genetic background of the recipient strain. 
u 
0  E  0 
E 
0.6 
0.5 
0.4 
0.3 
0.2 
0.1 
0.0 
B10 mice  CBA  mice 
-0.1 
B10/SELS24 
~,~  CBA/SELS12 
CBA/LaS12 
B10/LoS24 
=~'l~l'~ll._--.--,.-.ll.~  B10/NoS 
~E]''~'-"""~  CBA/NoS 
r--H  ,  ,  ,  , 
.Sal  -3  -2  -~  0 
.... CBA/SELS12 
L.._~  JI...  BIO/LaS~4 
B10/SELS2t  " 
,,--~"~"'-  ~  m0,,NoS  ~J"  , ~  ~.-..~---,--.o CBA/NoS 
^.~  ~,...~ ~//  --~,~  CBA/LaS12 
T~II  ,  ,  ,  , 
Sal  -3  -2  -I  0 
Log 2  serum  dilution 
FIGURE 5.  Monocyte  response of C57BL/10 mice (a) and CBA mice (b) expressed as the 
difference between the number of blood monocytes  at time zero and at 24 h after intravenous 
injection (A~4) of normal serum (I), LaS~4 (&), and SELS24 (0) from C57BL/10 mice, and of 
normal serum (f-l), LaS,~  (A), and SELS~ (O) from CBA mice. 532  GENETIC  CONTROL  OF  MONOCYTE  PRODUCTION 
O~  .b., 
>,, 
O  t- 
O 
E 
C3 
16.0 - 
12.0 " 
8,0 
z..0 
0.0 
-4.0 
8.0 
B10  mice 
/o../ 
/o  .// 
n...~ 
k~o~O~o 
I-'-I l  r  i  r  i 
Sol  -3  -2  -1  0 
8101LoS2z  , 
CBAISELS12 
CBA/LOS12 
B10/NoS 
CBA/NoS 
CBA mice 
A---.~ b._A/ 
r---t I  ,  ,  ,  , 
£al  -3  -2  -1  0 
BlOILoS24 
B10tSELS24 
CBA/NoS 
810/NoS 
CBA / LoS 12 
Log 2 serum  dilution 
FIGURE  6.  Monocyte  response  of C578L/10  mice (a) and  CBA  mice  (b) expressed  as the 
area under the curve (AUC) of the number of blood monocytes during 72 h after intravenous 
injection of normal serum (i), LaS24, (A), and SELS~4 (O) from C57BL/10 mice, and of normal 
serum (n), LaS~2 (A), and SELS~2 (©) from CBA mice. 
TABLE  II 
Regression Equations of Leukocyte Responses (Ae4 and AUC) after Injection of Serum Containing FIM 
and Normal Serum into B10 and CBA Mice 
Equation  No.  Serum  Regression  equation*  R ~t 
1  With ElM  A~4 monocytes  = 0.206 + 0.061  (dose × strain) + 0.321  (strain) -  0.670 (¢No)  0.803 
2  AUC monocytes  =  11.23 +  2.10 (dose × strain) +  t3.96 (strain) -  26.18 (,'No)  0.843 
3  A~4 granulocytes  =  0.931  -  0.301  (agent) -  1.087 (N0)  0.758 
4  AUC granulocytes  = 33.66 -  52.55 (No)  0,840 
5  A~4 lymphocytes =  13.744  -  4.457 (¢No)  0.699 
6  AUC lymphocytes  = 757.42 + 78.33 (strain) -  64.39 (agent) -  250.43 (¢N0)  0.784 
7  Normal  A24 monocytes  = 0.151  -  0.011  (dose) -  0.922 (No)  0.614 
8  AUC monocytes  = 6.45 -  44.98 (N0)  01745 
* The statistical analyses for At4 values and AUC values of sera with FIM were based on  150 and 120 mice, respectively,  and those for normal 
sera, on 80 mice. Since blood leukocyte  responses  of B10 and CBA mice injected with homologous SELS had been  followed for only 24 h, 
these experiments could not be taken  into account  to calculate the AUC. The equations include only variables with significant correlation (at 
least P <  0.05,  but usually P < 0.00005).  Dose, the logarithm (base 2) of the serum dilution; strain,  the recipient mouse strain,  with the value 
1 for B10 and 0 (zero) for CBA mice; agent, the stimulus used to increase  the index of FIM activity, with the value 1 for latex and 0 (zero) 
for SEL; ?¢0, the number of cells x  lO'~/ml at time zero.  Notes  to equations:  (Eq.  1) When B10 mice are the recipients of homologous 
SELS,4, the regression  coefficient  -0.670 must be replaced  by -0.237; (Eq. 2) when BI0 or CBA mice receive  LaSl2 from CBA donor mice, 
the terms -16.68 (No) and -13.86 (N0) must be added, respectively;  (Eq.  3) when  CBA mice receive  homologous LaSIi or beterologous 
SELS2,, the terms +0.171 (¢N0) and -0.304 (,/No) must be added, respectively; (Eq. 4) when BI0 mice receive beterologous SELSI~, the term 
-52.55 (No) must be replaced  by -117.24 (No) and the term +63.07 (¢N0) must be added; when CBA mice receive  heterologous LaS2,, the 
term  -13.98  (¢N0) must be added; (Eq. 5) when  CBA mice  are  injected with homologous LaSts  or heterologous LaS~,, the regression 
coefficient  -4.457 must be replaced  by -4.825 or -5.275, respectively;  when Bl0 mice receive  heterolognus SELSIt, the term +0.177 (No) 
must be added; (Eq. 8) when B10 are injected with homologous normal serum, the regression  coefficient  must be replaced  by -32.25. 
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The CBA recipient  strain  had the value zero for the term strain,  which means 
that the course of the number of blood monocytes in CBA mice was not changed 
significantly by the  injection  of serum,  but depended solely on the number  of 
monocytes at time zero. B10 mice were assigned the value 1 for the term strain, 
and  therefore  the  product  of dose  x  strain  was  included  in  the  regression 
equation  (Table  II,  equations  1,  2),  which  indicates  that  a  dose-dependent 
monocytosis  can  be  evoked  in  B10  mice.  The  intensity  of this  response  is 
negatively influenced by the number of monocytes in the recipient mice at time 
zero,  as  expressed  by  the  negative  sign  of the  term  ,/No  in  these  regression 
equations.  The  regression  of the  monocyte response on  the  dose of serum  in 
B10 recipient mice is the same for all sera under study; other characteristics of 
the serum that could influence the slope of the regression lines, i.e., the genetic 
background of the donor strain and the inflammatory agent used to increase the 
index  of FIM  activity  in  the  serum,  had  P-to-enter  values  >0.05  and  were 
therefore not included. Taken  together,  this statistical analysis indicates that in 
sera from CBA and  B10 mice, FIM is the only factor that has an effect on the 
monocyte response. 
Similar multiple regression analyses were performed for the granulocyte and 
lymphocyte responses (Table II, equations 3-6). The term dose is not found in 
any of the regression  equations,  which means that sera containing  FIM do not 
have a  significant  dose-dependent effect on the number of blood granulocytes 
and lymphocytes in either of the recipient strains. 
I7~ Vivo Responses to Normal Serum 
To examine whether normal homologous or heterologous serum would influ- 
ence  the  number  of blood  monocytes  in  B10  and  CBA  mice,  serial  twofold 
dilutions of serum were injected and the course of the number of monocytes was 
followed up  to  72  h  after  injection.  The  results  showed that  within  the  dose 
range under study, the number of blood monocytes in both mouse strains stayed 
within the normal range as expressed by the Ae4 (Fig.  5 a and b) and AUC (Fig. 
6a and b) Multiple regression analysis showed that the number of blood mono- 
cytes of the recipients at time zero and the dose of serum contribute significantly 
(P <  0.0005 and P =  0.0425, respectively) to the number of monocytes expressed 
as A24 (Table II, equation 7). But compared with serum containing FIM activity, 
normal serum appears to reduce the number of monocytes in a dose-dependent 
way. Since this effect is very small and vanishes when the response is expressed 
as AUC (Table  II,  equation  8),  the physiological significance of this  finding is 
doubtful. 
Injection of normal B 10 or CBA serum had no significant effect on the course 
of the number of granulocytes or lymphocytes in B10 and CBA recipient mice 
(data not shown). 
Discussion 
The most important finding made in the present study concerns the correlation 
between the magnitude of the inflammatory response and the ability to respond 
to FIM by increased monocyte production. The inflammatory response to latex 
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the site of inflammation and monocytes in the circulation, was high in B10 mice 
and low in CBA mice. Both strains showed FIM in the peripheral blood after the 
onset of the inflammatory response. However, the intravenous injection of serum 
containing FIM into low responder CBA mice did not induce a response, whereas 
in high responder B10 mice, monocytosis was evoked. In neither of the strains 
did the course of granulocytes and  lymphocytes change  significantly after  the 
injection of serum containing  FIM, in accordance with the cell lineage-specific 
effect of FIM (3, 5). Since a numerical increase of monocytes after the injection 
of serum  containing  FIM  reflects  increased  monocyte production  (3,  5),  we 
concluded that only high responder mice are able to respond to FIM by increased 
monocyte production. 
Both  ways of expressing  the  response  to  FIM,  i.e.,  as  the  difference  (A24) 
between the number of monocytes at time zero and at 24 h after injection of a 
serum sample, or as the AUC of the number of monocytes during a 72-h period, 
are equally valid, since the correlation coefficients for both are very similar (A24, 
0.803; AUC, 0.843). 
Under  normal  conditions,  the  number  of peritoneal  macrophages  did  not 
differ significantly between the two strains under study, but the peripheral blood 
of  the  high  responder  BI0  mice  contained  slighty,  but  significantly,  more 
monocytes than did the low responder CBA mice. The differences in the course 
of the number of macrophages in the responder strain after the administration 
of latex particles and SEL indicate that although the genetic constitution of the 
mouse strain  determines  the ability to react  to an  inflammatory  stimulus,  the 
nature of the inflammatory stimulus influences the kinetics of the inflammatory 
reaction.  To exclude the possibility that the absence of a  macrophage response 
in CBA mice was due to age (15), a similar study with latex as the inflammatory 
stimulus was done in older (i.e.,  6 mo old) mice.  In these mice, the number of 
peritoneal  macrophages  and  the number of blood monocytes did not increase 
significantly (data not shown). These findings make it unlikely that the difference 
in magnitude  of the inflammatory responses of high and low responder strains 
was due to the age of the low responder strain. 
High and low responder mice differ with respect to the increase of monocytes 
and  macrophages  after  an  inflammatory  stimulus.  However,  FIM,  which  is 
released by tissue macrophages  in  response  to a  phagocytic stimulus  (17),  was 
found in almost the same amounts in the serum of both mouse strains,  but the 
courses of the  FIM  activity were not exactly synchronous.  This  means  that  a 
defect  in  the  production  and  secretion  of FIM  by  macrophages  of the  low 
responder strain is very unlikely. Furthermore, in both mouse strains, the number 
of peritoneal  macrophages  that  had  ingested  latex  increased  with  increasing 
doses of latex (data not shown), and analysis of covariance showed no statistically 
significant differences. This indicates no appreciable differences in the phagocytic 
activity of macrophages of CBA and B10 mice. However, others have reported 
functional differences, e.g., chemotactic (8) and tumoricidal activity (16), between 
macrophages of both mouse strains. 
The  innate  resistance  to  intracellular  pathogens  such  as Mycobacterium bovis 
bacillus Calmette-Guerin, Salmonella (~phimurium, and Leishmania donovani, where 
macrophages are the effector cells, is regulated by genes located on chromosome SLUITER  ET  AL.  535 
1, possibly limited to one locus or gene complex (17,  18).  The relation between 
this locus and the gene that controls resistance to Listeria monocytogenes (19) is not 
yet clear. The finding that, in radiation chimeras, susceptibility to L. monocytogenes 
is determined not by the characteristics  of the donor mice, but by those of the 
recipient mice (20), is not consistent with the results of the present study. Since 
the mechanism underlying the difference in the response of B 10 and CBA mice 
to injected FIM is not fully understood, the chimeras study cannot be interpreted 
in  this  respect.  It seems likely, however,  that  the differences in  FIM  response 
involve a difference in the sensitivity of the monocyte precursor cells to FIM. 
Summary 
Previous studies have shown that  monocyte production during an inflamma- 
tory  response  is  controlled  by  the  factor  increasing  monocytopoiesis  (FIM), 
secreted by macrophages at the site of inflammation.  The inflammatory reaction 
to  latex  particles  and  a  saline-soluble  extract  of Listeria  monocytogenes  (SEL), 
expressed as the number of monocytes in the circulation and of macrophages at 
the site of inflammation, was about twice as strong in C57BL/10 mice compared 
with CBA mice. This raised the question as to the mechanism  underlying these 
differences. One possibility might be that these mouse strains differ with respect 
to the production  of FIM, but this  cannot  be the case because the  maximum 
levels of FIM activity in the serum of both C57BL/10 and CBA mice given latex 
or SEL  intraperitoneally  were almost  the  same;  however,  the  courses of FIM 
activity in  the two strains after intraperitoneal  latex were not exactly synchro- 
nous.  Another possibility is that  the sensitivity of monocyte precursor cells for 
FIM  differs.  Evidence  for  the  latter  was  provided  by  the  finding  that  the 
intravenous  injection  of sera  with  FIM  activity obtained  from  C57BL/10 and 
from  CBA mice  into  the  C57BL/10  mice  evoked monocytosis, whereas  CBA 
mice did not respond  to these sera.  Earlier  studies showed that  an increase of 
monocytes after the injection of serum containing  FIM reflects increased mon- 
ocyte production. Taken together,  the results of the present study demonstrate 
that one of the mechanisms underlying the genetic control of the inflammatory 
response is, rather than enhanced FIM synthesis, the ability of monocyte precur- 
sors in the bone marrow to respond to FIM by increased monocyte production. 
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